LANTHEUS HOLDINGS INC (LNTH)

US5165441032 - Common Stock

86.98  +0.53 (+0.61%)

Fundamental Rating

7

LNTH gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. LNTH gets an excellent profitability rating and is at the same time showing great financial health properties. LNTH has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! These ratings would make LNTH suitable for value and growth and quality investing!



8

1. Profitability

1.1 Basic Checks

LNTH had positive earnings in the past year.
In the past year LNTH had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: LNTH reported negative net income in multiple years.
In the past 5 years LNTH always reported a positive cash flow from operatings.

1.2 Ratios

LNTH has a Return On Assets of 20.86%. This is amongst the best in the industry. LNTH outperforms 98.40% of its industry peers.
LNTH's Return On Equity of 36.25% is amongst the best of the industry. LNTH outperforms 98.40% of its industry peers.
LNTH has a better Return On Invested Capital (29.79%) than 99.47% of its industry peers.
Industry RankSector Rank
ROA 20.86%
ROE 36.25%
ROIC 29.79%
ROA(3y)4.55%
ROA(5y)3.98%
ROE(3y)10.32%
ROE(5y)11.2%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Profit Margin value of 28.57%, LNTH belongs to the best of the industry, outperforming 97.33% of the companies in the same industry.
LNTH's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 31.69%, LNTH belongs to the top of the industry, outperforming 98.40% of the companies in the same industry.
LNTH's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 64.78%, LNTH is in the better half of the industry, outperforming 66.84% of the companies in the same industry.
LNTH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 31.69%
PM (TTM) 28.57%
GM 64.78%
OM growth 3Y88.56%
OM growth 5Y16.03%
PM growth 3YN/A
PM growth 5Y16.4%
GM growth 3Y13.64%
GM growth 5Y4.73%

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so LNTH is creating value.
The number of shares outstanding for LNTH has been reduced compared to 1 year ago.
Compared to 5 years ago, LNTH has more shares outstanding
LNTH has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 6.25 indicates that LNTH is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.25, LNTH belongs to the top of the industry, outperforming 81.28% of the companies in the same industry.
LNTH has a debt to FCF ratio of 1.49. This is a very positive value and a sign of high solvency as it would only need 1.49 years to pay back of all of its debts.
LNTH has a better Debt to FCF ratio (1.49) than 88.24% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that LNTH is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, LNTH is in the better half of the industry, outperforming 66.84% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 1.49
Altman-Z 6.25
ROIC/WACC3.47
WACC8.58%

2.3 Liquidity

LNTH has a Current Ratio of 1.65. This is a normal value and indicates that LNTH is financially healthy and should not expect problems in meeting its short term obligations.
LNTH has a worse Current ratio (1.65) than 74.87% of its industry peers.
LNTH has a Quick Ratio of 1.56. This is a normal value and indicates that LNTH is financially healthy and should not expect problems in meeting its short term obligations.
LNTH's Quick ratio of 1.56 is on the low side compared to the rest of the industry. LNTH is outperformed by 61.50% of its industry peers.
The current and quick ratio evaluation for LNTH is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.56

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.63% over the past year.
The Earnings Per Share has been growing by 45.36% on average over the past years. This is a very strong growth
The Revenue has grown by 24.15% in the past year. This is a very strong growth!
The Revenue has been growing by 30.43% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)18.63%
EPS 3Y121.92%
EPS 5Y45.36%
EPS Q2Q%15.65%
Revenue 1Y (TTM)24.15%
Revenue growth 3Y56.32%
Revenue growth 5Y30.43%
Sales Q2Q%18.37%

3.2 Future

Based on estimates for the next years, LNTH will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.82% on average per year.
The Revenue is expected to grow by 15.40% on average over the next years. This is quite good.
EPS Next Y9.36%
EPS Next 2Y7.38%
EPS Next 3Y9.82%
EPS Next 5Y14.82%
Revenue Next Year18.32%
Revenue Next 2Y12.16%
Revenue Next 3Y13.25%
Revenue Next 5Y15.4%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.53, which indicates a correct valuation of LNTH.
95.19% of the companies in the same industry are more expensive than LNTH, based on the Price/Earnings ratio.
LNTH's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.65.
LNTH is valuated correctly with a Price/Forward Earnings ratio of 12.11.
Based on the Price/Forward Earnings ratio, LNTH is valued cheaply inside the industry as 95.19% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.56. LNTH is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 12.53
Fwd PE 12.11

4.2 Price Multiples

92.51% of the companies in the same industry are more expensive than LNTH, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, LNTH is valued cheaper than 93.05% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.97
EV/EBITDA 10.64

4.3 Compensation for Growth

LNTH's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
LNTH has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.34
PEG (5Y)0.28
EPS Next 2Y7.38%
EPS Next 3Y9.82%

0

5. Dividend

5.1 Amount

No dividends for LNTH!.
Industry RankSector Rank
Dividend Yield N/A

LANTHEUS HOLDINGS INC

NASDAQ:LNTH (11/21/2024, 12:41:51 PM)

86.98

+0.53 (+0.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.05B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 12.53
Fwd PE 12.11
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.34
PEG (5Y)0.28
Profitability
Industry RankSector Rank
ROA 20.86%
ROE 36.25%
ROCE
ROIC
ROICexc
ROICexgc
OM 31.69%
PM (TTM) 28.57%
GM 64.78%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.65
Quick Ratio 1.56
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)18.63%
EPS 3Y121.92%
EPS 5Y
EPS Q2Q%
EPS Next Y9.36%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)24.15%
Revenue growth 3Y56.32%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y